Naproxen Sodium
- Product NDC
- 50268-592
- 11-digit product format
- 502680592
- Labeler code
- 50268
- Product ID
- 50268-592_b74afaaf-1442-41fe-8fab-f5dce214fff6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA078432
- Marketing category
- ANDA
- Marketing start
- 2007-04-26
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN SODIUM
- Active strength
- 275 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50268-592 | NAPROXEN SODIUM TABLET [AVPAK] | 8 | Legacy NDC | 20240105_9316bbe0-a194-d2a8-8f86-6d39e4d8f20e.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-592-15 | 50268059215 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-592-15) > 1 TABLET in 1 BLISTER PACK (50268-592-11) | 50 blister pack | 2012-10-16 | 0000-00-00 | No | No | Current |